Genetic analysis reveals that FMD viruses from North African and Middle Eastern epidemics are distinct from classical European vaccine strains.
This is the authors' abstract. We don't add key points for this paper.
The nucleotide sequences of the 3' end of the capsid-coding region were determined for 30 serotype O foot-and-mouth disease (FMD) viruses isolated between 1987 and 1994 from outbreaks in North Africa and the Middle East. These sequences were compared with the previously published sequences of 9 field virus isolates from the Middle East and 5 vaccine virus strains, 3 of which originated from the Middle East (O1/Turkey/Manisa/69, O1/Sharquia/Egypt/72 and O1/Israel/2/85) and 2 from Europe (O1/Lausanne/Switzerland/65 and O2/Brescia/Italy/47). Cluster analysis of these sequences using the unweighted pair group mean average (UPGMA) method showed: (i) that the FMD viruses isolated from North Africa and the Middle East were very different from the classical European vaccine strains; (ii) that all the viruses isolated during the 1989-92 North African epidemic formed a cluster differing by no more than 6% from each other; (iii) a virus isolated in Libya in 1988 was unrelated to the aforementioned epidemic; and (iv) viruses from a second, less extensive epidemic, occurring in 1994, fell into yet another cluster.
Answers are grounded in this paper and cite their sources.
North African/Middle Eastern FMD strains differ from European vaccines; leaves open need for region-specific vaccine updates in future outbreaks.
No takes yet. Share an insight, caveat, or question.
Samuel et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: